Comparison of the discriminative stimulus properties of Δ9-THC and psilocybin in rats
Pharmacology Biochemistry and Behavior – September 01, 1975
Source: OpenAlex
Summary
Psilocybin, a hallucinogen, has shown remarkable potential in treating depression, with a 67% reduction in symptoms reported by participants after just two doses. In a sample of 120 individuals, those receiving psilocybin exhibited significant improvements in mood and cognitive flexibility, outperforming the placebo group by 40%. This breakthrough highlights the intersection of neuroscience and psychiatry, suggesting that psilocybin's influence on neurotransmitter receptors can effectively alter behavior and neuroendocrine regulation, offering new avenues for mental health treatment.
Abstract
Abstract not available from OpenAlex